Cargando…
A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets
MYB activation is proposed to underlie development of adenoid cystic cancer (ACC), an aggressive salivary gland tumor with no effective systemic treatments. To discover druggable targets for ACC, we performed global mRNA/miRNA analyses of 12 ACC with matched normal tissues, and compared these data w...
Autores principales: | Gao, Ruli, Cao, Chunxia, Zhang, Min, Lopez, Maria-Cecilia, Yan, Yuanqing, Chen, Zirong, Mitani, Yoshitsugu, Zhang, Li, Zajac-Kaye, Maria, Liu, Bin, Wu, Lizi, Renne, Rolf, Baker, Henry V., El-Naggar, Adel, Kaye, Frederic J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350357/ https://www.ncbi.nlm.nih.gov/pubmed/25587024 |
Ejemplares similares
-
N-Terminal Truncated Myb with New Transcriptional Activity Produced Through Use of an Alternative MYB Promoter in Salivary Gland Adenoid Cystic Carcinoma
por: Frerich, Candace A., et al.
Publicado: (2019) -
Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional Study
por: Persson, Marta, et al.
Publicado: (2022) -
MYB promotes the growth and metastasis of salivary adenoid cystic carcinoma
por: Xu, Li-Hua, et al.
Publicado: (2019) -
An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma
por: Drier, Yotam, et al.
Publicado: (2016) -
Clinicopathologic implications of Myb and Beta-catenin expression in adenoid cystic carcinoma
por: Park, Susan, et al.
Publicado: (2020)